After years of investigation, the outgoing chairman of the Senate Health, Education, Labor and Pensions Committee has released his take on new legislation to reform the controversial 340B Drug Pricing Program. Sen. Bill Cassidy, R-Louisiana, unveiled a legislative discussion draft that would stand as the first statutory update to the subsidy program in 15 years if introduced and signed into law. Broadly, it contains a slew of measures that have been vehemently opposed by the hospital industry, such as allowances for drug manufacturers to offer upfront discounts or rebates following the submission of claims data “in order to reduce diversion or duplication of discounts,” as well as regular reporting from participating nonprofits on their 340B revenues, costs and eligibility.
Read the full article: Cassidy’s New Plan to Overhaul 340B: Rebates, Contract Pharmacy Limits and More Changes //
Source: https://www.fiercehealthcare.com/providers/cassidys-new-plan-reform-340b-rebates-contract-pharmacy-limits-and-more